Publications by authors named "Angeline Einarsen"
Background: Prolonged labor is a common condition associated with maternal and perinatal complications. The standard treatment with oxytocin for augmentation of labor increases the risk of adverse outcomes. Hyoscine butylbromide is a spasmolytic drug with few side effects shown to shorten labor when used in a general population of laboring women.
View Article and Find Full Text PDFArticle Synopsis
- First-time mothers often experience prolonged labor, which can affect about 20% of them and lead to negative birth outcomes; oxytocin is commonly used but has drawbacks.
- This study aims to determine if the antispasmodic drug butylscopolamine bromide (Buscopan®) can effectively shorten labor duration for first-time mothers who show signs of slow progress, as assessed by the World Health Organization partograph.
- Conducted at Oslo University Hospital, the trial will involve 250 women, comparing the effects of butylscopolamine to a placebo on labor duration, pain levels, need for oxytocin, delivery method, and overall maternal experience.